COFCO Biotechnology Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 14,896.32 million compared to CNY 18,086.36 million a year ago. Revenue was CNY 14,896.32 million compared to CNY 18,086.36 million a year ago.

Net income was CNY 965.43 million compared to CNY 935.09 million a year ago. Basic earnings per share from continuing operations was CNY 0.5195 compared to CNY 0.5055 a year ago. Diluted earnings per share from continuing operations was CNY 0.5195 compared to CNY 0.5041 a year ago.